STDs and STIs are having a profound impact on sexual and reproductive health globally. Every year, there are an estimated 376 million new infections. Gonorrhoea, Chlamydia, Syphilis and Trichomoniasis are most commonly seen. HSV and HPV are the viruses causing these infections. These are causing the major death in women and newborns which need to be focused on.
In 2017, global STD testing market was valued for $ 86,548.0 million. It is predicted to reach USD 133,935.7 million by 2025, at a CAGR of 5.6% from 2018- 2025. The diagnosis of these STDs caused by Syphilis is rising and is expected to account for over 20% of the market by 2022, growing at a CAGR over the forecast period due to high prevalence of syphilis infections globally.
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Vaccines and Immunizations Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Lower Respiratory and Pediatric IDs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Prevention and Control Public Health and Epidemiology Oral and Maxillofacial Infections Genomics and Infectious disease Special Session on COVID-19
Infection Prevention Conferences 2022 Virology Conferences Communicable Diseases Conferences 2022 Epidemiology Conferences Immunologists Conferences 2022 Infection Conferences Infectious Diseases Conferences Epidemiology Conferences 2022 Infection Control Conferences Infection Conferences 2022 USA Parasitology Conferences Infectious Diseases Conferences Middle East Vaccines conferences Infection Conferences 2022 Pathology Conferences